Global Anti Obesity Devices Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017 to 2021 and Forecast 2022 to 2028

$ PRICE - $ 3,000.00$ 8,900.00

Anti-Obesity Devices Market by Product Type (Gastric Bands, Electrical Stimulation System, Gastric Balloon System, Gastric Emptying System, Appetite Suppressors), by Method of deployment (Trans-oral, Endoscopy, Surgery), by End User (Hospitals, Gastroenterology clinics, Ambulatory surgical centres), and Geography.

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Categories: ,

Report

Description

Anti-Obesity Devices Market size was valued at USD 2.72 billion in 2021, growing at a CAGR of 10.1% during the forecast period 2022-2028. Obesity is a medical condition that can be defined as abnormal or excessive fat accumulation, which may have the negative effect on health. According to World Health Organisation, a person with BMI of 30 or more is generally considered as obese. Obesity increases the chances of diseases like chronic diseases, including diabetes, cardiovascular diseases, osteoarthritis, and certain types of cancers.This market mainly caused by excessive food intake, lack of physical, exercise, genetic inheritance, and rarely it occurs due to endocrine disorders, medications, and mental disorders. U.S. Food and Drug Administration approved the anti-obesity devices for the treatment of obesity. Obesity can be overcome the market. Conventionally, anti-obesity devices are expected to dominate in the obesity treatment market due to the ease of administration and lesser cost, and minimal invasiveness. FDA has approved the various types of anti-obesity devices, which may affect the growth of the market positively. For instance, In January 2015, FDA has approved EnteroMedics Inc.’s Vbloc Maestro system intended to treat morbid obesity. Similarly, in February 2011, Allergan got approval for anti-obesity device Lap-band, the adjustable gastric band used in the treatment of obesity. With an increasing number of device approvals, the anti-obesity market is anticipated to have a positive outlook in the forecast period. In January 2017, GI Dynamics Inc.’s EndoBarrier receives German NUB reimbursement status 1 for type 2 diabetes and obesity therapy

Anti Obesity Devices Market

MARKET SUMMARY
-
10.1% CAGR
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 10.1%
  • Largest Market– North America
  • Fastest Growing Market– North America

Anti Obesity Devices Market

  • The report on global anti-obesity devices market gives historical, current, and future market sizes (US$ Bn) on the basis of product type, method of deployment, end user and region
  • anti-obesity devices market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
Market Key Players
  • Allergan, Inc. (U.S.)
  • Medtronic. (Covidien PLC) (U.S.)
  • EnteroMedics, Inc (U.S.)
  • Cousin Biotech (France)
  • Surgical IOC (Peters Surgical SAS) (France)
  • PARE Surgical Inc. (U.S.)
  • GI Dynamics (U.S.)
Anti Obesity Devices Market Dynamics

The global anti obesity devices, expected to grow at a significant CAGR due to increase in the prevalence of obesity. According to WHO, obesity has doubled since 2015. In 2014 around 13% of adults aged 18 years or above were obese, and cause of death of approximately 2.8 Mn people annually around the globe. Rising demand for less invasive procedures for obesity treatment has significantly affected the growth of the market. Similarly, increase in disposable income in developing countries, and recent product approvals from U.S. Food and Drug Administration for new anti obesity devices are the major factors boosting the growth of the market. However, the side effects associated with the use of these devices, availability of medications for obesity, and product failure in some cases might hamper the growth of the market over the forecast period.


North-America got significant share

Anti Obesity Devices Market

Geographically, the anti obesity devices market has been segmented into following regions Viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America dominates the markets followed by Europe and Asia-Pacific. North American region is witnessed significant growth owing to the rise in a number of obese patients, according to American Heart Association, 70% American adults are obese or overweight. Moreover, according to the WHO in the European region, in 2012, about 50% of adults are suffering from obesity, which plays a key role in the global market growth. The Asia Pacific region is a key market for global anti-obesity due to the increase in obese patients, improving healthcare expenditure, and higher investments in healthcare which is expected to fuel the market for anti obesity devices in Asia Pacific region.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Key Features of the Report

  • The report provides granular level information about the market size, regional market share and forecast from 2021-2027
  • The report covers in-detail insights about the competitor’s overview, key findings and their key strategies
  • The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry
  • The report tracks recent innovations, key developments and startup’s details that are working in the industry
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
Segmentation

Anti Obesity Devices Market


Location

GEOGRAPHY

Frequently Asked Questions

The anti-obesity devices market is projected to expand at a CAGR of 10.2% during the forecast period

Allergan, Inc. (U.S.), Medtronic. (Covidien PLC) (U.S.), EnteroMedics, Inc (U.S.), Cousin Biotech (France), Surgical IOC (Peters Surgical SAS) (France)

North America is the fastest-growing region for anti-obesity devices market


Report

Table Of Content

  1. Executive summary
  2. Global Anti-Obesity Devices Market Introduction
    • Global Anti-Obesity Devices Market– Taxonomy
    • Global Anti-Obesity Devices Market–Definitions
      • Product Type
      • End User
  1. Global Anti-Obesity Devices Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global Anti-Obesity Devices Market Dynamics – Factors Impact Analysis
    • Global Anti-Obesity Devices Market– Regulations
      • S
      • Europe
      • Japan
    • Global Anti-Obesity Devices Market– Recent Product Launches
  2. Global Anti-Obesity Devices Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
    • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market Oppurtunity Analysis
  3. Global Anti-OBesity Devices Market, By Product Type, 2013 – 2017 and Forecast, 2018 – 2024
    • Gastric Bands
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Electrical Stimulation System
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Gastric Balloon System
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Gastric Emptying System
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Appetite Suppressors
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Anti-Obesity Devices Market Forecast, By Method of Deployment, 2013 – 2017 and Forecast, 2018 – 2024
    • Trans-oral
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Endoscopy
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Surgery
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Anti-Obesity Devices Market Forecast, By End User, 2013 – 2017 and Forecast, 2018 – 2024
    • Hospitals
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Gastroenterology Clinics
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Ambulatory surgical centers
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Anti-Obesity Devices Market Forecast, By Region, 2013 – 2017 and Forecast, 2018 – 2024
    • North America
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Europe
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia-Pacific
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Middle East and Africa
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Global Anti-Obesity Devices Market- Opportunity Analysis Index – By Product Type, By Method of Deployment, By End User, and Region, 2018 – 2024
  2. North America Anti-Obesity Devices Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
    • Product Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Gastric Bands
      • Electrical Stimulation System
      • Gastric Balloon System
      • Gastric Emptying System
      • Appetite Suppressors
    • Method of Deployment Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Trans-oral
      • Endoscopy
      • Surgery
    • End User Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Gastroenterology clinics
      • Ambulatory surgical centers
    • Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • S.
      • Canada
    • North America Anti-Obesity Devices Market- Opportunity Analysis Index – By Product Type, By Method of Deployment, By End User, and Country, 2018 – 2024
    • North America Anti-Obesity Devices Market Dynamics – Trends
  3. Europe Anti-Obesity Devices Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
    • Product Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Gastric Bands
      • Electrical Stimulation System
      • Gastric Balloon System
      • Gastric Emptying System
      • Appetite Suppressors
    • Method of Deployment Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Trans-oral
      • Endoscopy
      • Surgery
    • End User Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Gastroenterology clinics
      • Ambulatory surgical centers
    • Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Germany
      • UK
      • France
      • Spain
      • Italy
      • Russia
      • Poland
      • Rest of Europe
    • Europe Anti-Obesity Devices Market- Opportunity Analysis Index – By Product Type, By Method of Deployment, By End User, and Country, 2018 – 2024
    • Europe Anti-Obesity Devices Market Dynamics – Trends
  4. Asia-Pacific Anti-Obesity Devices Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
    • Product Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Gastric Bands
      • Electrical Stimulation System
      • Gastric Balloon System
      • Gastric Emptying System
      • Appetite Suppressors
    • Method of Deployment Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Trans-oral
      • Endoscopy
      • Surgery
    • End User Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Gastroenterology clinics
      • Ambulatory surgical centers
    • Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn),
  5. Y-o-Y Growth (%), and Market Share (%)
    • Japan
    • China
    • India
    • ASEAN
    • Australia & New Zealand
    • Rest of Asia-Pacific
  • Asia-Pacific Anti-Obesity Devices Market- Opportunity Analysis Index – By Product Type, By Method of Deployment, By End User, and Country, 2018 – 2024
  • Asia-Pacific Anti-Obesity Devices Market Dynamics – Trends
  1. Latin America Anti-Obesity Devices Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
    • Product Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Gastric Bands
      • Electrical Stimulation System
      • Gastric Balloon System
      • Gastric Emptying System
      • Appetite Suppressors
    • Method of Deployment Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Trans-oral
      • Endoscopy
      • Surgery
    • End User Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Gastroenterology clinics
      • Ambulatory surgical centers
    • Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Brazil
      • Mexico
      • Argentina
      • Venezuela
      • Rest of Latin America
    • Latin America Anti-Obesity Devices Market- Opportunity Analysis Index – By Product Type, By Method of Deployment, By End User, and Country, 2018 – 2024
    • Latin America Anti-Obesity Devices Market Dynamics – Trends
  2. Middle East & Africa Anti-Obesity Devices Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
    • Product Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Gastric Bands
      • Electrical Stimulation System
      • Gastric Balloon System
      • Gastric Emptying System
      • Appetite Suppressors
    • Method of Deployment Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Trans-oral
      • Endoscopy
      • Surgery
    • End User Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Gastroenterology clinics
      • Ambulatory surgical centers
    • Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Gulf Cooperation Council (GCC) Countries
      • Israel
      • South Africa
      • Rest of MEA
    • MEA Anti-Obesity Devices Market- Opportunity Analysis Index – By Product Type, By Method of Deployment, By End User, and Country, 2018 – 2024
    • MEA Anti-Obesity Devices Market Dynamics – Trends
  3. Competition Landscape
    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
      • Allergan, Inc. (U.S.)
      • (Covidien PLC) (U.S.)
      • EnteroMedics, Inc (U.S.)
      • Cousin Biotech (France)
      • Surgical IOC (Peters Surgical SAS) (France)
      • PARE Surgical Inc. (U.S.)
      • GI Dynamics (U.S.)
  1. Research Methodology
  2. Key Assumptions and Acronyms

Report

Company Profile

  • Allergan, Inc. (U.S.)
  • Medtronic. (Covidien PLC) (U.S.)
  • EnteroMedics, Inc (U.S.)
  • Cousin Biotech (France)
  • Surgical IOC (Peters Surgical SAS) (France)
  • PARE Surgical Inc. (U.S.)
  • GI Dynamics (U.S.)

Description

Anti-Obesity Devices Market size was valued at USD 2.72 billion in 2021, growing at a CAGR of 10.1% during the forecast period 2022-2028. Obesity is a medical condition that can be defined as abnormal or excessive fat accumulation, which may have the negative effect on health. According to World Health Organisation, a person with BMI of 30 or more is generally considered as obese. Obesity increases the chances of diseases like chronic diseases, including diabetes, cardiovascular diseases, osteoarthritis, and certain types of cancers.This market mainly caused by excessive food intake, lack of physical, exercise, genetic inheritance, and rarely it occurs due to endocrine disorders, medications, and mental disorders. U.S. Food and Drug Administration approved the anti-obesity devices for the treatment of obesity. Obesity can be overcome the market. Conventionally, anti-obesity devices are expected to dominate in the obesity treatment market due to the ease of administration and lesser cost, and minimal invasiveness. FDA has approved the various types of anti-obesity devices, which may affect the growth of the market positively. For instance, In January 2015, FDA has approved EnteroMedics Inc.’s Vbloc Maestro system intended to treat morbid obesity. Similarly, in February 2011, Allergan got approval for anti-obesity device Lap-band, the adjustable gastric band used in the treatment of obesity. With an increasing number of device approvals, the anti-obesity market is anticipated to have a positive outlook in the forecast period. In January 2017, GI Dynamics Inc.’s EndoBarrier receives German NUB reimbursement status 1 for type 2 diabetes and obesity therapy

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX